Chatiemac Consulting

Chatiemac Consulting is a private consulting firm focused on strategic and commercial planning for biotechnology companies. Publicly available references describe the firm as providing guidance to companies developing therapies for rare diseases, rather than operating as a drug developer with its own therapeutic pipeline. The business appears to be a small, founder-led life sciences consultancy associated with Christine A. Nash. Available records indicate it was formed in California in 2018 and remains active. Based on the available evidence, Chatiemac Consulting should be characterized as a healthcare/biotech advisory business rather than a biotech, pharma, CRO, or platform therapeutics company.